Work

Olanzapine for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC): Alliance A221301, a randomized, double-blind, placebo-controlled trial.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.29_suppl.176

Authors: Rudolph M. Navari, Rui Qin, Kathryn Jean Ruddy, Heshan Liu, Steven Francis Powell, Madhuri Bajaj, Leah L. Dietrich, Jacqueline M. Lafky, Charles L. Loprinzi

Institutions: Indiana University South Bend, Indiana University School of Medicine, Mayo Clinic, Sanford Health, Illinois CancerCare, Gundersen Health System

Language: English

Topic: Nausea and vomiting management

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2318547355

Cites:

Cited by: 12

Related to: 10